Home / EphB4 / Mouse EphB4 Antibody

Mouse EphB4 Antibody

Catalog #: AF446
52 Citations 2 Reviews Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
AF446
AF446-SP
EphB4 in Mouse Embryo.
4 Images
Product Details
Citations (52)
FAQs
Supplemental Products
Reviews (2)
Summary Data Examples Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Mouse EphB4 Antibody Summary

Species Reactivity
Mouse
Specificity
Detects mouse EphB4 in direct ELISAs and Western blots. In direct ELISAs, approximately 5% cross-reactivity with recombinant mouse (rm) EphB6 and rmEphA3 is observed and less than 1% cross-reactivity with rmEphA2, rmEphA4, rmEphA6, rmEphA7, rmEphA8, rmEphB2, and rmEphB3 is observed.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse EphB4
Leu16-Ala539
Accession # P54761
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Applications

Recommended Concentration
Sample
Western Blot
0.1 µg/mL
Recombinant Mouse EphB4 Fc Chimera (Catalog # 446-B4)
Flow Cytometry
2.5 µg/106 cells
MCF‑7 human breast cancer cell line
Immunohistochemistry
5-15 µg/mL
See below
CyTOF-ready
Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.
 

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Immunohistochemistry EphB4 antibody in Mouse Embryo by Immunohistochemistry (IHC-Fr). View Larger

EphB4 in Mouse Embryo. EphB4 was detected in immersion fixed frozen sections of mouse embryo (15 d.p.c.) using Goat Anti-Mouse EphB4 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF446) at 15 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Frozen Tissue Sections.

Western Blot Detection of Mouse EphB4 by Western Blot View Larger

Detection of Mouse EphB4 by Western Blot Reduced Eph-B4 activity increases venous neointimal thickening. (A) Representative photomicrographs (left panel) and bar graph (right panel) showing AVF venous limb wall thickness in control and Eph-B4 het mice (day 21); *P = 0.047 (t-test). n = 8. Scale bar 25 µm. (B) Line graph showing infrarenal IVC diameter in control or Eph-B4 het mice; *P = 0.59 (ANOVA). n = 8–9. (C) Representative Western blot showing inhibited tyrosine phosphorylation in the Y774F-Eph-B4 mutant compared to the WT-Eph-B4 construct (0–60 min). (D) Bar graph showing Ephrin-B2/Fc stimulated COS cell migration after transfection with WT-Eph-B4 or Y774F-Eph-B4 plasmids. P < 0.0001 (ANOVA); *P < 0.0001 Ephrin-B2/Fc WT-Eph-B4 vs Y774F-Eph-B4. n = 3–4. (E) Representative photomicrographs (left panel) showing AVF venous wall (elastin stain) in control mice or mice treated with WT-Eph-B4 or mutant Y774F-Eph-B4. Arrow heads denote neointimal thickness. Scale bar, 25 µm. Bar graph (right panel) showing quantification of AVF venous wall thickness in control mice (white bar) or mice treated with WT-Eph-B4 (gray bar) or mutant Y774F-Eph-B4 (blue bar), day 21; P = 0.035 (ANOVA). *P = 0.038 (WT-Eph-B4 vs Y774F-Eph-B4; post hoc). n = 5–7. (F) Line graph showing infrarenal IVC diameter in mice with AVF treated with WT-Eph-B4 (gray line) or mutant Y774F-Eph-B4 (purple line) compared to control (black line); *P = 0.005 (ANOVA). n = 5–11. Data represent mean ± SEM. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/29133876), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human EphB4 by Western Blot View Larger

Detection of Human EphB4 by Western Blot Increased Eph-B4 and Ephrin-B2 expression during adaptive venous remodeling. (A) Western blot and adjacent bar graph of densitometry showing human Eph-B4 expression in AVF venous limb compared to normal vein. *P = 0.0016; t-test. n = 3–4. (B) Line graphs show expression of Eph-B4 (blue) and Ephrin-B2 (red) in the AVF venous limb compared to sham IVC; P < 0.0001 (ANOVA). *P < 0.05 (P = 0.0123, Eph-B4; P = 0.0041, Ephrin-B2; post hoc); **P < 0.05 (P < 0.0001, Ephrin-B2; post hoc). n = 5–8. (C) Western blots showing Eph-B4 and Ephrin-B2 protein expression in AVF venous limb compared to sham IVC. n = 3–5. (D) Graphs showing densitometry of Eph-B4 (left panel) and Ephrin-B2 (right panel) expression in the AVF venous limb compared to sham IVC; *P < 0.05 (P < 0.0001, Eph-B4 day 7, AVF vs sham; P < 0.0001, Eph-B4 day 21, AVF vs sham; P < 0.0001, Ephrin-B2 day 7, AVF vs sham; post hoc). n = 3–5. (E) Diagram of rat model showing location of infrarenal IVC pericardial patch exposed to an aortocaval AVF (n = 6 per group). (F) Representative Western blot (upper panel) showing Eph-B4 and Ephrin-B2 expression in patch neointima (day 14) of control vein compared to patch neointima of AVF vein. Graphs (lower panel) show quantification of western blot bands; P < 0.0001 (ANOVA). *P < 0.05 (P = 0.0003, Eph-B4; P = 0.0043, Ephrin-B2; post hoc). n = 3. (G) Representative photomicrographs (upper panel) showing Eph-B4 (green) and Ephrin-B2 (red) immunoreactive signal (day 14). White arrowheads indicate colocalization of Eph-B4 and Ephrin-B2. L, vessel lumen. Graph (lower panel) shows quantification of immunoreactive signal; P < 0.0001 (ANOVA). *P < 0.05 (P = 0.0136 Eph-B4; P < 0.0001 Ephrin-B2; post hoc). n = 3. Scale bar 100 µm. Data represent mean ± SEM. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/29133876), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human EphB4 by Western Blot View Larger

Detection of Human EphB4 by Western Blot Increased Eph-B4 and Ephrin-B2 expression during adaptive venous remodeling. (A) Western blot and adjacent bar graph of densitometry showing human Eph-B4 expression in AVF venous limb compared to normal vein. *P = 0.0016; t-test. n = 3–4. (B) Line graphs show expression of Eph-B4 (blue) and Ephrin-B2 (red) in the AVF venous limb compared to sham IVC; P < 0.0001 (ANOVA). *P < 0.05 (P = 0.0123, Eph-B4; P = 0.0041, Ephrin-B2; post hoc); **P < 0.05 (P < 0.0001, Ephrin-B2; post hoc). n = 5–8. (C) Western blots showing Eph-B4 and Ephrin-B2 protein expression in AVF venous limb compared to sham IVC. n = 3–5. (D) Graphs showing densitometry of Eph-B4 (left panel) and Ephrin-B2 (right panel) expression in the AVF venous limb compared to sham IVC; *P < 0.05 (P < 0.0001, Eph-B4 day 7, AVF vs sham; P < 0.0001, Eph-B4 day 21, AVF vs sham; P < 0.0001, Ephrin-B2 day 7, AVF vs sham; post hoc). n = 3–5. (E) Diagram of rat model showing location of infrarenal IVC pericardial patch exposed to an aortocaval AVF (n = 6 per group). (F) Representative Western blot (upper panel) showing Eph-B4 and Ephrin-B2 expression in patch neointima (day 14) of control vein compared to patch neointima of AVF vein. Graphs (lower panel) show quantification of western blot bands; P < 0.0001 (ANOVA). *P < 0.05 (P = 0.0003, Eph-B4; P = 0.0043, Ephrin-B2; post hoc). n = 3. (G) Representative photomicrographs (upper panel) showing Eph-B4 (green) and Ephrin-B2 (red) immunoreactive signal (day 14). White arrowheads indicate colocalization of Eph-B4 and Ephrin-B2. L, vessel lumen. Graph (lower panel) shows quantification of immunoreactive signal; P < 0.0001 (ANOVA). *P < 0.05 (P = 0.0136 Eph-B4; P < 0.0001 Ephrin-B2; post hoc). n = 3. Scale bar 100 µm. Data represent mean ± SEM. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/29133876), licensed under a CC-BY license. Not internally tested by R&D Systems.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Loading...
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: EphB4

EphB4, also known as Htk, Myk1, Tyro11, and Mdk2 (1), is a member of the Eph receptor family which binds members of the ephrin ligand family. There are two classes of receptors, designated A and B. Both the A and B class receptors have an extracellular region consisting of a globular domain, a cysteine-rich domain, and two fibronectin type III domains. This is followed by the transmembrane region and cytoplasmic region. The cytoplasmic region contains a juxtamembrane motif with two tyrosine residues, which are the major autophosphorylation sites, a kinase domain, and a conserved sterile alpha motif (SAM) in the carboxy tail which contains one conserved tyrosine residue. Activation of kinase activity occurs after ligand recognition and binding. EphB4 has been shown to bind ephrin‑B2 and ephrin‑B1 (2, 3). The extracellular domains of human and mouse EphB4 share 88% amino acid identity. Only membrane-bound or Fc-clustered ligands are capable of activating the receptor in vitro. While soluble monomeric ligands bind the receptor, they do not induce receptor autophosphorylation and activation (2). In vivo, the ligands and receptors display reciprocal expression (3). It has been found that nearly all receptors and ligands are expressed in developing and adult neural tissue (3). The Eph/ephrin families also appear to play a role in angiogenesis (3).

References
  1. Eph Nomenclature Committee [letter] (1997) Cell 90:403.
  2. Flanagan, J.G. and P. Vanderhaeghen (1998) Annu. Rev. Neurosci. 21:309.
  3. Pasquale, E.B. (1997) Curr. Opin. Cell Biol. 9:608.
Long Name
Eph Receptor B4
Entrez Gene IDs
2050 (Human); 13846 (Mouse)
Alternate Names
EC 2.7.10; EC 2.7.10.1; EPH receptor B4; EphB4; ephrin type-B receptor 4; hepatoma transmembrane kinase; Htk; HTKephrin receptor EphB4; Mdk2; Myk1; soluble EPHB4 variant 1; soluble EPHB4 variant 2; soluble EPHB4 variant 3; Tyro11; Tyrosine-protein kinase receptor HTK; Tyrosine-protein kinase TYRO11

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Citations for Mouse EphB4 Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

52 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Cerebral Vein Malformations Result from Loss of Twist1 Expression and BMP Signaling from Skull Progenitor Cells and Dura
    Authors: Max A. Tischfield, Caroline D. Robson, Nicole M. Gilette, Shek Man Chim, Folasade A. Sofela, Michelle M. DeLisle et al.
    Developmental Cell
  2. Rapid remodeling of airway vascular architecture at birth.
    Authors: Ni A, Lashnits E, Yao LC et al.
    Dev Dyn
  3. Expression of axon guidance ligands and their receptors in the cornea and trigeminal ganglia and their recovery after corneal epithelium injury
    Authors: Victor H. Guaiquil, Cissy Xiao, Daniel Lara, Greigory Dimailig, Qiang Zhou
    Experimental Eye Research
  4. Pericardial patch venoplasty heals via attraction of venous progenitor cells
    Authors: Bai H, Wang M, Foster TR et al.
    Physiol Rep
  5. Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2
    Authors: Johanna Liebl, Siwei Zhang, Markus Moser, Yan Agalarov, Cansaran Saygili Demir, Bianca Hager et al.
    Nature Communications
  6. Semaphorin 3d signaling defects are associated with anomalous pulmonary venous connections
    Authors: Karl Degenhardt, Manvendra K Singh, Haig Aghajanian, Daniele Massera, Qiaohong Wang, Jun Li et al.
    Nature Medicine
  7. Inhibition of EphB4-ephrin-B2 signaling reprograms the tumor immune microenvironment in head and neck cancers
    Authors: S Bhatia, A Oweida, S Lennon, LB Darragh, D Milner, AV Phan, AC Mueller, B Van Court, D Raben, NJ Serkova, XJ Wang, A Jimeno, ET Clambey, EB Pasquale, SD Karam
    Cancer Res., 2019-03-20;0(0):.
  8. BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development
    Authors: Reema B. Davis, Carol D. Curtis, Courtney T. Griffin
    Development
  9. An EPHB4-RASA1 signaling complex inhibits shear stress-induced Ras-MAPK activation in lymphatic endothelial cells to promote the development of lymphatic vessel valves
    Authors: Chen, D;Wiggins, D;Sevick, EM;Davis, MJ;King, PD;
    bioRxiv : the preprint server for biology
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  10. Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations
    Authors: Zhao, S;Mekbib, KY;van der Ent, MA;Allington, G;Prendergast, A;Chau, JE;Smith, H;Shohfi, J;Ocken, J;Duran, D;Furey, CG;Hao, LT;Duy, PQ;Reeves, BC;Zhang, J;Nelson-Williams, C;Chen, D;Li, B;Nottoli, T;Bai, S;Rolle, M;Zeng, X;Dong, W;Fu, PY;Wang, YC;Mane, S;Piwowarczyk, P;Fehnel, KP;See, AP;Iskandar, BJ;Aagaard-Kienitz, B;Moyer, QJ;Dennis, E;Kiziltug, E;Kundishora, AJ;DeSpenza, T;Greenberg, ABW;Kidanemariam, SM;Hale, AT;Johnston, JM;Jackson, EM;Storm, PB;Lang, SS;Butler, WE;Carter, BS;Chapman, P;Stapleton, CJ;Patel, AB;Rodesch, G;Smajda, S;Berenstein, A;Barak, T;Erson-Omay, EZ;Zhao, H;Moreno-De-Luca, A;Proctor, MR;Smith, ER;Orbach, DB;Alper, SL;Nicoli, S;Boggon, TJ;Lifton, RP;Gunel, M;King, PD;Jin, SC;Kahle, KT;
    Nature communications
    Species: Primate - Chlorocebus aethiops (African Green Monkey)
    Sample Types: Cell Lysates
    Applications: Immunoprecipitation
  11. Genetic dysregulation of an endothelial Ras signaling network in vein of Galen malformations
    Authors: S Zhao, KY Mekbib, MA van der En, G Allington, A Prendergas, JE Chau, H Smith, J Shohfi, J Ocken, D Duran, CG Furey, HT Le, PQ Duy, BC Reeves, J Zhang, C Nelson-Wil, D Chen, B Li, T Nottoli, S Bai, M Rolle, X Zeng, W Dong, PY Fu, YC Wang, S Mane, P Piwowarczy, KP Fehnel, AP See, BJ Iskandar, B Aagaard-Ki, AJ Kundishora, T DeSpenza, ABW Greenberg, SM Kidanemari, AT Hale, JM Johnston, EM Jackson, PB Storm, SS Lang, WE Butler, BS Carter, P Chapman, CJ Stapleton, AB Patel, G Rodesch, S Smajda, A Berenstein, T Barak, EZ Erson-Omay, H Zhao, A Moreno-De-, MR Proctor, ER Smith, DB Orbach, SL Alper, S Nicoli, TJ Boggon, RP Lifton, M Gunel, PD King, SC Jin, KT Kahle
    bioRxiv : the preprint server for biology, 2023-03-21;0(0):.
    Species: Zebrafish
    Sample Types: Cell Lysates
    Applications: Immunoprecipitation
  12. Eph/Ephrin Promotes the Adhesion of Liver Tissue-Resident Macrophages to a Mimicked Surface of Liver Sinusoidal Endothelial Cells
    Authors: S Kohara, K Ogawa
    Biomedicines, 2022-12-12;10(12):.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: Bioassay
  13. Histochemical examination of blood vessels in murine femora with intermittent PTH administration
    Authors: H Maruoka, S Zhao, H Yoshino, M Abe, T Yamamoto, H Hongo, M Haraguchi-, A Nasoori, H Ishizu, Y Nakajima, M Omaki, T Shimizu, N Iwasaki, PH Luiz de Fr, M Li, T Hasegawa
    Journal of oral biosciences, 2022-05-15;0(0):.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  14. Tracheal separation is driven by NKX2-1-mediated repression of Efnb2 and regulation of endodermal cell sorting
    Authors: AE Lewis, A Kuwahara, J Franzosi, JO Bush
    Cell Reports, 2022-03-15;38(11):110510.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IF
  15. Expression and localisation of ephrin-B1 and EphB4 in steroidogenic cells in the naturally cycling mouse ovary
    Authors: J Alam, K Ogawa
    Reproductive biology, 2021-05-13;21(3):100511.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  16. Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells
    Authors: C Donato, L Kunz, F Castro-Gin, A Paasinen-S, K Strittmatt, BM Szczerba, R Scherrer, N Di Maggio, W Heusermann, O Biehlmaier, C Beisel, M Vetter, C Rochlitz, WP Weber, A Banfi, T Schroeder, N Aceto
    Cell Rep, 2020-09-08;32(10):108105.
    Species: Human, Mouse
    Sample Types: Cell Lysates
    Applications: Western Blot
  17. Endothelial EphB4 maintains vascular integrity and transport function in adult heart
    Authors: G Luxán, J Stewen, N Díaz, K Kato, SK Maney, A Aravamudha, F Berkenfeld, N Nagelmann, HC Drexler, D Zeuschner, C Faber, H Schillers, S Hermann, J Wiseman, JM Vaquerizas, ME Pitulescu, RH Adams
    Elife, 2019-11-29;8(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  18. Regulatory pathways governing murine coronary vessel formation are dysregulated in the injured adult heart
    Authors: S Payne, M Gunadasa-R, A Neal, AN Redpath, J Patel, KM Chouliaras, I Ratnayaka, N Smart, S De Val
    Nat Commun, 2019-07-22;10(1):3276.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-Fr
  19. Venous identity requires BMP signalling through ALK3
    Authors: A Neal, S Nornes, S Payne, MD Wallace, M Fritzsche, P Louphrasit, RN Wilkinson, KM Chouliaras, K Liu, K Plant, R Sholapurka, I Ratnayaka, W Herzog, G Bond, T Chico, G Bou-Ghario, S De Val
    Nat Commun, 2019-01-28;10(1):453.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC, IHC-P
  20. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF
    Authors: E Groppa, S Brkic, A Uccelli, G Wirth, P Korpisalo-, M Filippova, B Dasen, V Sacchi, MG Muraro, M Trani, S Reginato, R Gianni-Bar, S Ylä-Herttu, A Banfi
    EMBO Rep., 2018-04-11;0(0):.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-Fr
  21. Histochemical assessment for osteoblastic activity coupled with dysfunctional osteoclasts in c-src deficient mice
    Authors: H Toray, T Hasegawa, N Sakagami, E Tsuchiya, A Kudo, S Zhao, Y Moritani, M Abe, T Yoshida, T Yamamoto, T Yamamoto, K Oda, N Udagawa, PH Luiz de Fr, M Li
    Biomed. Res., 2017-01-01;38(2):123-134.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  22. EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance
    Nat Commun, 2016-07-29;7(0):12329.
    Species: Mouse
    Sample Types: Tissue Homogenates
    Applications: Western Blot
  23. Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol
    J Exp Clin Cancer Res, 2016-07-22;35(1):118.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  24. EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis
    J Clin Invest, 2016-07-11;0(0):.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-Fr
  25. Eph-B4 mediates vein graft adaptation by regulation of endothelial nitric oxide synthase
    Authors: M Wang, MJ Collins, TR Foster, H Bai, T Hashimoto, JM Santana, C Shu, A Dardik
    J. Vasc. Surg., 2016-01-24;65(1):179-189.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: Western Blot
  26. EphB4 Expressing Stromal Cells Exhibit an Enhanced Capacity for Hematopoietic Stem Cell Maintenance.
    Authors: Nguyen T, Arthur A, Panagopoulos R, Paton S, Hayball J, Zannettino A, Purton L, Matsuo K, Gronthos S
    Stem Cells, 2015-06-23;33(9):2838-49.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: Western Blot
  27. EphB4 forward signalling regulates lymphatic valve development.
    Authors: Zhang, Gu, Brady, John, Liang, Wei-Chin, Wu, Yan, Henkemeyer, Mark, Yan, Minhong
    Nat Commun, 2015-04-13;6(0):6625.
    Species: Mouse
    Sample Types: Tissue Homogenates
    Applications: Western Blot
  28. The in vivo effect of prophylactic subchondral bone protection of osteoarthritic synovial membrane in bone-specific Ephb4-overexpressing mice.
    Authors: Valverde-Franco G, Hum D, Matsuo K, Lussier B, Pelletier J, Fahmi H, Kapoor M, Martel-Pelletier J
    Am J Pathol, 2014-11-29;185(2):335-46.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  29. Single-cell western blotting.
    Authors: Hughes A, Spelke D, Xu Z, Kang C, Schaffer D, Herr A
    Nat Methods, 2014-06-01;11(7):749-55.
    Species: Rat
    Sample Types: Cell Lysates
    Applications: Western Blot
  30. Molecular identification of venous progenitors in the dorsal aorta reveals an aortic origin for the cardinal vein in mammals.
    Authors: Lindskog, Henrik, Kim, Yung Hae, Jelin, Eric B, Kong, Yupeng, Guevara-Gallardo, Salvador, Kim, Tyson N, Wang, Rong A
    Development, 2014-03-01;141(5):1120-8.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  31. Sox17 is required for normal pulmonary vascular morphogenesis.
    Authors: Lange A, Haitchi H, LeCras T, Sridharan A, Xu Y, Wert S, James J, Udell N, Thurner P, Whitsett J
    Dev Biol, 2014-01-10;387(1):109-20.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  32. A novel feedback mechanism by Ephrin-B1/B2 in T-cell activation involves a concentration-dependent switch from costimulation to inhibition.
    Authors: Kawano H, Katayama Y, Minagawa K, Shimoyama M, Henkemeyer M, Matsui T
    Eur. J. Immunol., 2012-05-23;42(6):1562-72.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: Immunoprecipitation, Western Blot
  33. Eph-B4 prevents venous adaptive remodeling in the adult arterial environment.
    Authors: Muto A, Yi T, Harrison KD, Davalos A, Fancher TT, Ziegler KR, Feigel A, Kondo Y, Nishibe T, Sessa WC, Dardik A
    J. Exp. Med., 2011-02-21;208(3):561-75.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  34. EphB-ephrin-B2 interactions are required for thymus migration during organogenesis.
    Authors: Foster KE, Gordon J, Cardenas K
    Proc. Natl. Acad. Sci. U.S.A., 2010-07-08;107(30):13414-9.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  35. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
    Authors: Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Luthi U, Barberis A, Benjamin LE, Makinen T, Nobes CD, Adams RH
    Nature, 2010-05-27;465(7297):483-6.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  36. Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development.
    Authors: Lin FJ, Chen X, Qin J, Hong YK, Tsai MJ, Tsai SY
    J. Clin. Invest., 2010-04-01;120(5):1694-707.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  37. Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice.
    Authors: Xie J, Wu T, Xu K, Huang IK, Cleaver O, Huang CL
    Am. J. Pathol., 2009-07-30;175(3):1315-27.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-Fr
  38. Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis.
    Authors: Kim YH, Hu H, Guevara-Gallardo S, Lam MT, Fong SY, Wang RA
    Development, 2008-11-01;135(22):3755-64.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-Fr
  39. EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts.
    Authors: Allan EH, Hausler KD, Wei T, Gooi JH, Quinn JM, Crimeen-Irwin B, Pompolo S, Sims NA, Gillespie MT, Onyia JE, Martin TJ
    J. Bone Miner. Res., 2008-08-01;23(8):1170-81.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: Western Blot
  40. Dynamic changes occur in patterns of endometrial EFNB2/EPHB4 expression during the period of spiral arterial modification in mice.
    Authors: Zhang J, Dong H, Wang B, Zhu S, Croy BA
    Biol. Reprod., 2008-05-07;79(3):450-8.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  41. The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization.
    Authors: Yang NY, Pasquale EB, Owen LB, Ethell IM
    J. Biol. Chem., 2006-08-31;281(43):32574-86.
    Species: Mouse
    Sample Types: Cell Lysates, Whole Cells
    Applications: Flow Cytometry, Immunoprecipitation, Western Blot
  42. EphB2 and ephrin-B1 expressed in the adult kidney regulate the cytoarchitecture of medullary tubule cells through Rho family GTPases.
    Authors: Ogawa K, Wada H, Okada N, Harada I, Nakajima T, Pasquale EB, Tsuyama S
    J. Cell. Sci., 2006-02-01;119(0):559-70.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  43. Inhibition of tumor growth and angiogenesis by soluble EphB4.
    Authors: Martiny-Baron G, Korff T, Schaffner F, Esser N, Eggstein S, Marme D, Augustin HG
    Neoplasia, 2004-05-01;6(3):248-57.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  44. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Authors: Fuller T, Korff T, Kilian A, Dandekar G, Augustin HG
    J. Cell. Sci., 2003-05-06;116(0):2461-70.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  45. Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII
    Authors: Man Chu, Taotao Li, Bin Shen, Xudong Cao, Haoyu Zhong, Luqing Zhang et al.
    eLife
  46. Why some tumours trigger neovascularisation and others don’t: the story thus far
    Authors: Omanma Adighibe, Russell D. Leek, Marta Fernandez-Mercado, Jiangting Hu, Cameron Snell, Kevin C. Gatter et al.
    Chinese Journal of Cancer
  47. Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence
    Authors: Beatriz Morancho, Águeda Martínez-Barriocanal, Josep Villanueva, Joaquín Arribas
    Breast Cancer Research
  48. Single-Cell Western Blotting
    Authors: Elly Sinkala, Amy E. Herr
    Methods in Molecular Biology
  49. SMAD4 prevents flow induced arterial-venous malformations by inhibiting Casein Kinase 2
    Authors: Roxana Ola, Sandrine H. Künzel, Feng Zhang, Gael Genet, Raja Chakraborty, Laurence Pibouin-Fragner et al.
    Circulation
  50. EphB4 mediates resistance to antiangiogenic therapy in experimental glioma
    Authors: Christian Uhl, Moritz Markel, Thomas Broggini, Melina Nieminen, Irina Kremenetskaia, Peter Vajkoczy et al.
    Angiogenesis
  51. Absence of venous valves in mice lacking Connexin37
    Authors: Stephanie J. Munger, John D. Kanady, Alexander M. Simon
    Developmental Biology
  52. Aberrant EphB/ephrin-B expression in experimental gastric lesions and tumor cells
    Authors: Shintaro Uchiyama, Noritaka Saeki, Kazushige Ogawa
    World Journal of Gastroenterology

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Mouse EphB4 Antibody

Average Rating: 4 (Based on 2 Reviews)

5 Star
50%
4 Star
0%
3 Star
50%
2 Star
0%
1 Star
0%

Have you used Mouse EphB4 Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Mouse EphB4 Antibody
By Anonymous on 12/16/2020
Application: Immunocytochemistry/Immunofluorescence Sample Tested: E12.5 mouse embryo fixed in 4% PFA Species: Mouse

Dilution used - 1:200. The staining was done on an E12.5 transverse (4% PFA fixed) mouse section using standard IF techniques.
Used 1% BSA for blocking for 1 hour before adding the primary antibody.
The results are hit or miss for me, because I have noticed expression on non target tissue (Sometimes it doesn't appear, sometimes it does).
Attached pictures shows a artery (smaller circle) and a vein (bigger circle), and while the EphB4 expression on the vein is very good (as it is supposed to express there), there seems to be some non-specific expression on the adjacent artery as well.

Immunocytochemistry/Immunofluorescence Mouse EphB4 Antibody AF446
Mouse EphB4 Antibody
By Anonymous on 11/13/2020
Application: WB Sample Tested: embryos Species: Zebrafish
Western Blot Mouse EphB4 Antibody AF446